<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We described a patient of refractory cytomegalovirus (CMV) limbic <z:hpo ids='HP_0002383'>encephalitis</z:hpo> who received matched unrelated bone marrow transplantation </plain></SENT>
<SENT sid="1" pm="."><plain>Pyrosequencing study on serial cerebrospinal fluid samples revealed the emergence of resistant strains associated with exposure of <z:chebi fb="1" ids="22587">antiviral agents</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>Combinations of <z:chebi fb="1" ids="22587">antiviral agents</z:chebi> had a role in partial suppression of CMV <z:mp ids='MP_0001799'>viral</z:mp> load but the clearance of virus mainly relied on the recovery of host's immunity and resulted in intact survival of host </plain></SENT>
<SENT sid="3" pm="."><plain>Donor's CMV-seronegative status may contribute to the delay in controlling this serious <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Prompt identification of drug-resistant mutant helps in selection of <z:chebi fb="1" ids="22587">antiviral agents</z:chebi> </plain></SENT>
</text></document>